104 related articles for article (PubMed ID: 21103674)
21. Additional benefit of dietitian involvement in dialysis staffs-led diet education on uncontrolled hyperphosphatemia in hemodialysis patients.
Tsai WC; Yang JY; Luan CC; Wang YJ; Lai YC; Liu LC; Peng YS
Clin Exp Nephrol; 2016 Oct; 20(5):815-821. PubMed ID: 26658792
[TBL] [Abstract][Full Text] [Related]
22. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
Dong J; Wang H; Wang M
J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
[TBL] [Abstract][Full Text] [Related]
23. Behavioral modeling to guide adherence to fluid control in hemodialysis patients.
Ghaddar S; Shamseddeen W; Elzein H
J Ren Nutr; 2009 Mar; 19(2):153-60. PubMed ID: 19218042
[TBL] [Abstract][Full Text] [Related]
24. Patient education: an efficient adjuvant therapy for hyperphosphatemia in hemodialysis patients.
Sun CY; Chang KC; Chen SH; Chang CT; Wu MS
Ren Fail; 2008; 30(1):57-62. PubMed ID: 18197544
[TBL] [Abstract][Full Text] [Related]
25. Effect of individual health education on hyperphosphatemia in the Hakkas residential area.
Chen Y; Li Z; Liang X; Zhang M; Zhang Y; Xu L; Zhong L; Shi W
Ren Fail; 2015; 37(8):1303-7. PubMed ID: 26275110
[TBL] [Abstract][Full Text] [Related]
26. Hyperphosphatemia in patients with ESRD: assessing the current evidence linking outcomes with treatment adherence.
Covic A; Rastogi A
BMC Nephrol; 2013 Jul; 14():153. PubMed ID: 23865421
[TBL] [Abstract][Full Text] [Related]
27. Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Itoh K; Tanaka M; Hashiguchi J; Funakoshi S; Nakano H; Kubo H; Kono T; Uchino J; Masaki K; Date T; Shigematsu T;
Ther Apher Dial; 2008 Apr; 12(2):126-32. PubMed ID: 18387160
[TBL] [Abstract][Full Text] [Related]
28. Efficacy and safety of sevelamer. Comparison with calcium carbonate in the treatment of hyperphosphatemia in hemodialysis patients.
Shaheen FA; Akeel NM; Badawi LS; Souqiyyeh MZ
Saudi Med J; 2004 Jun; 25(6):785-91. PubMed ID: 15195212
[TBL] [Abstract][Full Text] [Related]
29. Adherence to treatment and personality in renal failure.
Vives T; Pujolar N; Junyent E; Flores I; Cordovilla L; Izquierdo R
EDTNA ERCA J; 1999; 25(3):13-4, 18. PubMed ID: 10786487
[TBL] [Abstract][Full Text] [Related]
30. Phosphate control in chronic uremia: don't forget diet.
Cupisti A; Morelli E; D'Alessandro C; Lupetti S; Barsotti G
J Nephrol; 2003; 16(1):29-33. PubMed ID: 12649532
[TBL] [Abstract][Full Text] [Related]
31. Relation between response to illness and compliance in haemodialysis patients.
Saounatsou M
EDTNA ERCA J; 1999; 25(4):32-4. PubMed ID: 10827597
[TBL] [Abstract][Full Text] [Related]
32. Sevelamer reduces calcium load and maintains a low calcium-phosphorus ion product in dialysis patients.
Gallieni M; Cozzolino M; Carpani P; Zoni U; Brancaccio D
J Nephrol; 2001; 14(3):176-83. PubMed ID: 11439741
[TBL] [Abstract][Full Text] [Related]
33. Relationship between beliefs regarding a low salt diet in chronic renal failure patients on dialysis.
Agondi Rde F; Gallani MC; Rodrigues RC; Cornélio ME
J Ren Nutr; 2011 Mar; 21(2):160-8. PubMed ID: 20537916
[TBL] [Abstract][Full Text] [Related]
34. Prevention and control of phosphate retention/hyperphosphatemia in CKD-MBD: what is normal, when to start, and how to treat?
Martin KJ; González EA
Clin J Am Soc Nephrol; 2011 Feb; 6(2):440-6. PubMed ID: 21292848
[TBL] [Abstract][Full Text] [Related]
35. Knowledge of hemodialysis and CAPD patients about their prescribed medicines.
Blanchard R; Berger W; Bailie GR; Eisele G
Clin Nephrol; 1990 Oct; 34(4):173-8. PubMed ID: 2257703
[TBL] [Abstract][Full Text] [Related]
36. Phosphate elimination in modalities of hemodialysis and peritoneal dialysis.
Kuhlmann MK
Blood Purif; 2010; 29(2):137-44. PubMed ID: 20093819
[TBL] [Abstract][Full Text] [Related]
37. Dietary and fluid adherence in Iranian hemodialysis patients.
Rambod M; Peyravi H; Shokrpour N; Sareban MT
Health Care Manag (Frederick); 2010; 29(4):359-64. PubMed ID: 21045589
[TBL] [Abstract][Full Text] [Related]
38. Management of hyperphosphatemia.
Kuhlmann MK
Hemodial Int; 2006 Oct; 10(4):338-45. PubMed ID: 17014508
[TBL] [Abstract][Full Text] [Related]
39. Salivary glands: a new player in phosphorus metabolism.
Savica V; Calò LA; Santoro D; Monardo P; Santoro G; Muraca U; Davis PA; Bellinghieri G
J Ren Nutr; 2011 Jan; 21(1):39-42. PubMed ID: 21195917
[TBL] [Abstract][Full Text] [Related]
40. Patient-Reported Factors Associated With Poor Phosphorus Control in a Maintenance Hemodialysis Population.
Joson CG; Henry SL; Kim S; Cheung MY; Parab P; Abcar AC; Jacobsen SJ; Morisky DE; Sim JJ
J Ren Nutr; 2016 May; 26(3):141-8. PubMed ID: 26614738
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
